CA
NZ
UK
AU
IND
US
Hims & Hers Health (NYSE:HIMS) closed at USD 22.98 on November 9, down 11.77% in the regular session before its after-close report, then touched USD 20.63 in extended trading. The cause of the daytime fall was not confirmed, but the results deepened it. Third-quarter …
Life360 (NASDAQ:LIF) reported third-quarter revenue of USD 174.1 million on November 9, up 40% from USD 124.5 million and ahead of expectations, the fastest growth in this group. Subscription revenue rose 29% to USD 124.2 million, and advertising revenue jumped 250% to USD 25.4 …
ImmunityBio (NASDAQ:IBRX) fell about 20% on November 9 to around USD 6.89, from USD 8.64 the previous Friday, on more than twice its average volume. Third-quarter net product revenue from Anktiva rose 53% to USD 48.7 million, but total revenue of about USD 48.8 …
Onto Innovation (NYSE:ONTO) reported record third-quarter revenue of USD 409.7 million after the close on November 9, up 87.8% from USD 218.2 million and above the roughly USD 391.8 million expected. Non-GAAP earnings were USD 2.44 per share against USD 0.92 a year earlier, …
NRG Energy (NYSE:NRG) jumped 10.32% on November 9 after agreeing to sell six gas plants with 4.9 gigawatts of capacity to LS Power for USD 4 billion in cash, about 8.0 times expected 2027 EBITDA. The proceeds fund a clear capital plan: USD 3 …
Immunovant (NASDAQ:IMVT) rallied 15.1% to USD 35.15 from USD 30.53 after a positive rheumatoid arthritis study of IMVT-1402, which blocks the FcRn antibody-recycling receptor. In the randomizedWithdrawalperiod, 92.5% of patients on the 600 mg dose kept an ACR20 response at week 28, against 75.6% …
Faeth Therapeutics (NASDAQ:FTH) closed 42.5% lower on November 9, one of the steepest declines in the US market on a day when the S&P 500 rose about 2.4%. The trigger was preliminary Phase 2 PIK-201 data for its PIKTOR and paclitaxel combination in advanced …
The FDA on November 9 ordered new warnings on all GLP-1 drugs about non-arteritic anterior ischemic optic neuropathy, or NAION, a rare eye condition that can cause sudden vision loss, affecting products from Eli Lilly (NYSE:LLY) and Novo Nordisk. The agency's review of more …
AMD (NASDAQ:AMD) closed up 13.26% at USD 508.58 after an upgrade to Outperform with a USD 600 target, built on a forecast of 135%Data Centerrevenue growth in 2027. The upgrade expects data center sales to reach about 85% of revenue, with AI GPUs overtaking …
Bloom Energy (NYSE:BE) closed up 11.91% at USD 193.88 on November 9, touching USD 199.83 intraday, after a two-day slide of about 22% on the midtermData Centervotes. The rebound focused attention on two deals announced on November 5: 900 megawatts of onsite power for …
Please wait processing your request...